Modern drug development approaches that integrate functional plans with larger business goals are needed for success in early ...

SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of systemic ...

AbCellera Biologics' drug candidates in Phase 1 trials show promise, but financial losses and slow progress raise concerns.

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

New U.S. investor The Institute for Follicular Lymphoma Innovation (IFLI), a global non-profit foundation dedicated to advancing research and treatment for follicular lymphoma, invested $9 million in ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy ...

We expect that these clinical investigators will become leaders in a re ... and able to commit 75% of full-time professional effort to this Career Development Program and its related research ...

These forward-looking statements include statements regarding the clinical development of CLS-AX, CLS-AX’s potential impact on the wet AMD market, as well as the potential benefits of CLS-AX ...

today announces the in-licensing of two clinical-stage oncology programs from Astex Pharmaceuticals ('Astex'), a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd. Mosaic has identified ...